Clinical Trial Update: Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating prevention of contrast-induced nephropathy in diabetic patients undergoing coronary angiography.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: CardioVascular Research Foundation, Korea | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: UNKNOWN